$A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma$

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Dunn, Tamara J.; Dinner, Shira; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Hao, Ying; Berube, Caroline; Medeiros, Bruno C.; Liedtke, Michaela

期刊名称British Journal of Haematology
作者Dunn, Tamara J.; Dinner, Shira; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Hao, Ying; Berube, Caroline; Medeiros, Bruno C.; Liedtke, Michaela
卷第173卷
期第2期
印刷ISSN0007-1048
文件大小86.57KB
发表时间2016-04
DOI10.1111/bjh.13946
页码253-259

发现好书期刊，享受阅读乐趣

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma